https://www.selleckchem.com/products/GDC-0449.html
66; 95% CI, 1.08-2.54) and shorter PFS (P = .0059) and OS (P = .0003) for patients with lymphoma-related hypercalcemia but not independently of IPI parameters. These data suggest that hypercalcemia is rather a biomarker of the underlying biological aggressiveness of DLBCL. © 2020 John Wiley Sons Ltd.Since December, 2019, coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has spread to a lot of countries worldwide1,2 . On Jan 30, 2020, the World Health Organization (WHO) had declared that the outbreak of COVID-19 is a Publ
Like
Comment
Share
